Discontinuation report ACT GEMCITABINE
| Report ID | 63998 |
| Drug Identification Number | 02433117 |
| Brand name | ACT GEMCITABINE |
| Common or Proper name | GEMCITABINE |
| Company Name | ACTAVIS PHARMA COMPANY |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GEMCITABINE |
| Strength(s) | 38MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 |
| ATC code | L01BC |
| ATC description | ANTIMETABOLITES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-06-30 |
| Remaining supply date | 2018-06-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2018-10-12 | French | Compare |
| v1 | 2018-10-12 | English | Compare |
Showing 1 to 2 of 2